SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is experiencing a significant surge in momentum as the community anticipates groundbreaking clinical data for pancreatic and brain cancer treatments scheduled for presentation at major medical conferences. Investors are actively discussing the stock's transition into a catalyst-heavy phase, with enthusiasm fueled by favorable interim study results and recent analyst price target upgrades.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased trading activity as market participants digest a significant portfolio shake-up involving Berkshire Hathaway's full exit from the stock, which many community members view as a misplaced move following the company's recent strong performance and solid fundamentals. Traders are actively debating the stock's future trajectory, with many dismissing the recent price dip as an overreaction and identifying it as a buying opportunity in a defensive leader poised for continued growth.

Alpha Pro Tech Ltd. engages in the business of protecting people, products and environment. It develops, manufactures and markets disposable and limited use protective apparel products for the industries, clean room, medical and dental markets. The company operates through the Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment includes many different styles of disposable products, such as shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. The Building Supply segment consists of a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment. The company was founded in 1983 and is headquartered in Aurora, Canada.

Alpha Pro Tech Ltd.

Alpha Pro Tech is seeing renewed market interest driven by recent news headlines regarding respiratory viruses, causing traders to revisit the stock as a potential protective equipment play. The community is actively debating the stock's valuation relative to its tangible book value, with some seeing a bargain while others express skepticism over the lack of sustained growth catalysts outside of pandemic-related spikes.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending as investors weigh potential consumer spending fatigue and macroeconomic headwinds ahead of the earnings season, with the community actively debating whether the stock is an oversold value play or a long-term risk. Discussion focuses on how interest rates, ongoing remodeling demand, and institutional positioning influence its near-term recovery prospects.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye Global Inc. (MBLY) is trending as retail investors aggressively pile into the stock, anticipating a potential gamma squeeze and long-term gains from the company's expansion into physical AI and humanoid robotics. The community is sharply divided between bullish speculators betting on a rebound supported by a share buyback program and institutional analyst skepticism, while many are closely watching its deep integration with Intel's autonomous driving roadmap.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is attracting attention as it secures a significant purchase order for its SiCore silicon-anode batteries to power electric two and three-wheelers in the Chinese market. The community is actively debating the company's long-term growth potential and manufacturing strategy, with many monitoring whether warrant exchange activities and short interest levels will act as catalysts for future price movement.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is currently facing significant selling pressure as Treasury yields climb toward 5%, driven by intensifying inflation fears tied to the ongoing conflict in the Middle East and rising energy costs. Market participants are actively discussing the possibility of a debt-driven volatility spike, with many investors hedging against further downside through heavy put option activity while debating whether this represents a long-term bottom or the start of a deeper bond market rout.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing intense volatility as investors weigh a major institutional funding round at a premium against ongoing concerns over valuation and short-selling campaigns. The community remains sharply divided, with bulls pointing to the company's new AI networking partnerships as validation, while bears continue to scrutinize the company's operational transparency and recent share issuance.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the announcement of an exclusive supply agreement for the Tokyo-172 strain of BCG, a development investors hope will resolve long-standing U.S. supply shortages and bolster the commercial rollout of Anktiva. Community sentiment remains focused on the companys ongoing participation in the American Urological Association annual meeting, with many long-term shareholders anticipating that resolving supply bottlenecks and recent leadership changes at the FDA will accelerate clinical progress and alleviate short-selling pressure.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on the upcoming AUA Annual Meeting, where the company will present extended follow-up data for its prostate cancer therapy, CAN-2409. The community is actively discussing the potential for a premium buyout, the durability of trial results compared to existing standards of care, and the significant institutional confidence signaled by recent insider activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Company News for May 15, 2026

Companies In The News Are: NVMI, YETI, CLBT, DDS.

Yeti (YETI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Yeti (YETI) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Yeti (YETI) Tops Q1 Earnings and Revenue Estimates

Yeti (YETI) delivered earnings and revenue surprises of +50.03% and +1.62%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

YETI Reports First Quarter 2026 Results

YETI Holdings, Inc. (YETI) (NYSE: YETI) today announced its financial results for the first quarter ended April 4, 2026. First Quarter 2026 Highlights Sales increased 8%, driven by strong consumer...

Amer Sports, Inc. (AS) Reports Next Week: Wall Street Expects Earnings Growth

Amer Sports, Inc. (AS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PLBY Group, Inc. (PLBY) Reports Break-Even Earnings for Q1

PLBY Group (PLBY) delivered earnings and revenue surprises of -100.00% and +1.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ahead of Yeti (YETI) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Evaluate the expected performance of Yeti (YETI) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Callaway Golf (CALY) Tops Q1 Earnings and Revenue Estimates

Callaway (CALY) delivered earnings and revenue surprises of +34.26% and +5.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

YETI Holdings, Inc. (NYSE:YETI) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of YETI Holdings, Inc. (NYSE:YETI - Get Free Report) have been given an average rating of "Moderate Buy" by the sixteen research firms that are currently covering the firm, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating and nine have given a buy rating to...

YETI Holdings, Inc. $YETI Shares Sold by Van Berkom & Associates Inc.

Van Berkom & Associates Inc. lessened its stake in YETI Holdings, Inc. (NYSE:YETI - Free Report) by 5.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,620,914 shares of the company's stock after selling 91,446 shares during the period. YETI comprises approxi...

YETI Holdings, Inc. engages in the design, marketing, and distribution of products for the outdoor and recreation market. Its products include coolers, drinkware, travel bags, backpacks, multipurpose buckets, outdoor chairs, blankets, dog bowls, apparel, and accessories. The company was founded by Roy J. Seiders and Ryan R. Seiders in 2006 and is headquartered in Austin, TX.

Current Price	$42.67
Prev Close	$40.69
Open	$40.96
Dividend Yield	0.00%
50-Day Moving Average	$38.51
Beta	1.33
Avg. Volume	1.41M
PE Ratio	21.67

52-Week High	$51.29
52-Week Low	$28.98
Market Capitalization	$3.23B
EPS (Annual)	$2.03
Price to Book	4.90
Revenue Per Employee	$1.34M

YETI
YETI Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest YETI News

YETIYETI Holdings Inc